SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech vs. Shorts
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Neuroguy who wrote (318)1/14/2000 11:50:00 AM
From: Biomaven  Read Replies (2) of 427
 
Neuroguy,

My general view is that buying stocks just because they have short squeeze potential is a good way to go broke. I do agree that a big short position can sometimes add considerable zest to good news, however. (Although not always - SNRS hasn't done as well as might be expected today, for example).

In general the last few months have been unkind to the biotech shorters - CLPA, CYGN, CLTR, GLIA and SNRS have all had good news after earlier disappointments.

I am indeed still very long SEPR - it's my biggest position by a factor of 4, with NBIX and MLNM the distant runner-ups.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News